| Component |
Class |
Efficacy |
Length of Immunity |
Risk/Severity of Adverse Effects |
Comments |
| Canine Distemper |
Core |
High |
> 1 year for modified live virus (MLV) vaccines |
Low |
|
| Measles |
Noncore |
High in preventing disease, but not in preventing infection |
Long |
Infrequent |
Use in high risk environments for canine distemper in puppies 4-10 weeks of age |
| Parvovirus |
Core |
High |
> 1 year |
Low |
|
| Hepatitis |
Core |
High |
> 1 year |
Low |
Only use canine adenovirus-2 (CAV-2) vaccines |
| Rabies |
Core |
High |
Dependent upon type of vaccine |
Low to moderate |
|
| Respiratory disease from canine adenovirus-2 (CAV-2) |
Noncore |
Not adequately studied |
Short |
Minimal |
If vaccination warranted, boost annually or more frequently |
| Parainfluenza |
Noncore |
Intranasal MLV - Moderate Injectable MLV - Low |
Moderate |
Low |
Only recommended for dogs in kennels, shelters, shows, or large colonies; If vaccination warranted, boost annually or more frequently |
| Bordetella |
Noncore |
Intranasal MLV - Moderate Injectable MLV - Low |
Short |
Low |
For the most benefit, use intranasal vaccine 2 weeks prior to exposure |
| Leptospirosis |
Noncore |
Variable |
Short |
High |
Up to 30% of dogs may not respond to vaccine |
| Coronavirus |
Noncore |
Low |
Short |
Low |
Risk of exposure high in kennels, shelters, shows, breeding facilities |
| Lyme |
Noncore |
Appears to be limited to previously unexposed dogs; variable |
Revaccinate annually |
Moderate |
|
